A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes

Matthias G. J. Baud, Enrique Lin-Shiao, Teresa Cardote, Cynthia Tallant, Annica Pschibul, Kwok-Ho Chan, Michael Zengerle, Jordi R. Garcia, Terence T.-L. Kwan, Fleur M. Ferguson, Alessio Ciulli (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    73 Citations (Scopus)

    Abstract

    Small molecules are useful tools for probing the biological function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins. The Bromo and Extra-Terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer. The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors but these inhibitors lack selectivity for individual family members. We developed an ethyl derivative of an existing small-molecule inhibitor, I-BET, and showed that it binds Leu/Ala mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains. Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin. Expansion of this approach could help identify the individual roles of single BET proteins in human physiology and disease.
    Original languageEnglish
    Pages (from-to)638-641
    Number of pages4
    JournalScience
    Volume346
    Issue number6209
    DOIs
    Publication statusPublished - 31 Oct 2014

    Fingerprint

    Proteins
    Epigenomics
    Lysine
    Chromatin
    Cell Culture Techniques
    Neoplasms
    Therapeutics

    Cite this

    Baud, Matthias G. J. ; Lin-Shiao, Enrique ; Cardote, Teresa ; Tallant, Cynthia ; Pschibul, Annica ; Chan, Kwok-Ho ; Zengerle, Michael ; Garcia, Jordi R. ; Kwan, Terence T.-L. ; Ferguson, Fleur M. ; Ciulli, Alessio. / A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes. In: Science. 2014 ; Vol. 346, No. 6209. pp. 638-641.
    @article{3a7d18c323bc4a4f868feb77776cef3e,
    title = "A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes",
    abstract = "Small molecules are useful tools for probing the biological function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins. The Bromo and Extra-Terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer. The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors but these inhibitors lack selectivity for individual family members. We developed an ethyl derivative of an existing small-molecule inhibitor, I-BET, and showed that it binds Leu/Ala mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains. Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin. Expansion of this approach could help identify the individual roles of single BET proteins in human physiology and disease.",
    author = "Baud, {Matthias G. J.} and Enrique Lin-Shiao and Teresa Cardote and Cynthia Tallant and Annica Pschibul and Kwok-Ho Chan and Michael Zengerle and Garcia, {Jordi R.} and Kwan, {Terence T.-L.} and Ferguson, {Fleur M.} and Alessio Ciulli",
    note = "Copyright {\circledC} 2014, American Association for the Advancement of Science.",
    year = "2014",
    month = "10",
    day = "31",
    doi = "10.1126/science.1249830",
    language = "English",
    volume = "346",
    pages = "638--641",
    journal = "Science",
    issn = "0036-8075",
    publisher = "American Association for the Advancement of Science",
    number = "6209",

    }

    Baud, MGJ, Lin-Shiao, E, Cardote, T, Tallant, C, Pschibul, A, Chan, K-H, Zengerle, M, Garcia, JR, Kwan, TT-L, Ferguson, FM & Ciulli, A 2014, 'A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes', Science, vol. 346, no. 6209, pp. 638-641. https://doi.org/10.1126/science.1249830

    A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes. / Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T.-L.; Ferguson, Fleur M.; Ciulli, Alessio (Lead / Corresponding author).

    In: Science, Vol. 346, No. 6209, 31.10.2014, p. 638-641.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes

    AU - Baud, Matthias G. J.

    AU - Lin-Shiao, Enrique

    AU - Cardote, Teresa

    AU - Tallant, Cynthia

    AU - Pschibul, Annica

    AU - Chan, Kwok-Ho

    AU - Zengerle, Michael

    AU - Garcia, Jordi R.

    AU - Kwan, Terence T.-L.

    AU - Ferguson, Fleur M.

    AU - Ciulli, Alessio

    N1 - Copyright © 2014, American Association for the Advancement of Science.

    PY - 2014/10/31

    Y1 - 2014/10/31

    N2 - Small molecules are useful tools for probing the biological function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins. The Bromo and Extra-Terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer. The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors but these inhibitors lack selectivity for individual family members. We developed an ethyl derivative of an existing small-molecule inhibitor, I-BET, and showed that it binds Leu/Ala mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains. Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin. Expansion of this approach could help identify the individual roles of single BET proteins in human physiology and disease.

    AB - Small molecules are useful tools for probing the biological function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins. The Bromo and Extra-Terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer. The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors but these inhibitors lack selectivity for individual family members. We developed an ethyl derivative of an existing small-molecule inhibitor, I-BET, and showed that it binds Leu/Ala mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains. Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin. Expansion of this approach could help identify the individual roles of single BET proteins in human physiology and disease.

    U2 - 10.1126/science.1249830

    DO - 10.1126/science.1249830

    M3 - Article

    C2 - 25323695

    VL - 346

    SP - 638

    EP - 641

    JO - Science

    JF - Science

    SN - 0036-8075

    IS - 6209

    ER -